Sovran Advisors LLC Invests $1.38 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Sovran Advisors LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,529 shares of the healthcare conglomerate’s stock, valued at approximately $1,375,000.

A number of other hedge funds also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $27,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $37,000. Friedenthal Financial purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $51,000. Finally, Highline Wealth Partners LLC acquired a new position in UnitedHealth Group in the 3rd quarter worth $55,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.33% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on UNH shares. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. UBS Group lowered their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Finally, HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a report on Friday, January 10th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Up 1.2 %

Shares of NYSE:UNH opened at $533.17 on Tuesday. The firm has a market capitalization of $490.66 billion, a P/E ratio of 34.40, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a fifty day moving average of $529.18 and a two-hundred day moving average of $564.40.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.83 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.